Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant
The antigenic variation of influenza virus represents a major health problem, thus continuous efforts have been made to develop broad-spectrum vaccines against influenza virus. Matrix protein 1 (M1) protein is highly conserved in all influenza A strains. In this study, M1 protein was efficiently exp...
Saved in:
Published in | Vaccine Vol. 28; no. 48; pp. 7690 - 7698 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier Ltd
10.11.2010
Elsevier Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!